Crystalloid Fluids
Sterile saltwater solutions, including normal saline and lactated Ringer's, used for IV fluid administration in trauma resuscitation and general medical care.
In the Field
Crystalloid is the clear bag of fluid most people picture when they think of an IV drip. For decades, crystalloid was the answer to trauma resuscitation, with field providers pushing one or two liters into every significant bleeder. Modern doctrine has pulled back hard on that practice. Crystalloid does not carry oxygen, dilutes the patient's clotting factors, and can pop clots that have already formed. Today's tactical aid bags carry less crystalloid and more blood products. Knowing what crystalloid is and what it is not is the foundation of understanding why permissive hypotension and damage control resuscitation work the way they do.
Common Mistake
Treating crystalloid as a substitute for blood loss when it does not carry oxygen, lacks clotting factors, and can worsen coagulopathy at high volume
Technical Detail
Crystalloid fluids are sterile water-based solutions containing dissolved salts and other small molecules in concentrations approximating physiologic levels. The two crystalloid types most relevant to trauma care are:
Normal Saline (0.9 percent sodium chloride). Water with sodium chloride at a concentration of 0.9 percent. The most widely available IV fluid, used for general resuscitation, medication delivery, and dilution of certain medications. Large-volume normal saline administration can contribute to hyperchloremic metabolic acidosis.
Lactated Ringer's (LR). Water with sodium, potassium, calcium, chloride, and lactate in concentrations more closely approximating blood plasma. Lactate is metabolized by the liver and converted to bicarbonate, which can buffer acidosis. Generally preferred over normal saline for trauma resuscitation when crystalloid administration is indicated.
Other crystalloids exist (Plasma-Lyte, D5W, half-normal saline, hypertonic saline) with specific clinical uses but limited field relevance in tactical medicine.
What crystalloid does and does not do. Crystalloid expands intravascular volume temporarily, raising blood pressure and improving perfusion in the short term. It does not:
Carry oxygen. Crystalloid contains no red blood cells.
Carry clotting factors. Crystalloid contains no plasma proteins, fibrinogen, or other coagulation components.
Stay in the vascular space. Crystalloid distributes throughout the body's water compartments, with most of an administered dose leaving the bloodstream within hours.
The doctrine shift. Through the late 20th century, prehospital trauma protocols called for aggressive crystalloid administration in actively bleeding patients, often 1 to 2 liters or more. Outcome research and combat trauma data over the past two decades documented several harms from this approach:
Dilutional coagulopathy. Large crystalloid volumes dilute the patient's clotting factors, impairing coagulation.
Clot disruption. Restoring blood pressure to normal can dislodge clots that had begun to form, restarting bleeding.
Acidosis. Normal saline in particular contributes to metabolic acidosis when given in large volumes.
Hypothermia. Room-temperature crystalloid lowers core body temperature, contributing to the Lethal Triad.
Edema and reperfusion injury. Excess fluid produces tissue swelling and contributes to organ dysfunction.
Modern doctrine. Current TCCC, TECC, and major civilian trauma protocols favor:
Limited or no crystalloid in actively bleeding trauma patients.
Permissive hypotension targets rather than restoration to normal blood pressure.
Blood products over crystalloid where available.
TXA administration within the three-hour window.
See the Permissive Hypotension and Damage Control Resuscitation entries for the full doctrinal context.
When crystalloid is still appropriate. Crystalloid remains useful for:
Maintaining IV line patency.
Diluting medications for IV administration.
Replacing fluid losses in non-hemorrhagic conditions (heat illness, burns where appropriate per protocol, prolonged transport).
Patients with traumatic brain injury where higher cerebral perfusion pressure is needed (modified permissive hypotension).
Specific clinical situations per protocol.
Procurement implications. The shift in resuscitation doctrine has reduced the volume of crystalloid carried in tactical aid bags while increasing the emphasis on blood products and TXA. Modern aid bag specifications typically include:
A small volume of crystalloid (often 250 to 500 mL bags rather than 1-liter bags) for IV access maintenance and medication delivery.
TXA for trauma patients within the three-hour window.
Blood products where forward-deployed capability exists.
Warming equipment for patients and (where blood products are carried) for the products themselves.
For agencies updating tactical medical specifications, the question is no longer how much crystalloid to carry but rather how to integrate blood product capability and reduce crystalloid reliance.
Normal Saline (0.9 percent sodium chloride). Water with sodium chloride at a concentration of 0.9 percent. The most widely available IV fluid, used for general resuscitation, medication delivery, and dilution of certain medications. Large-volume normal saline administration can contribute to hyperchloremic metabolic acidosis.
Lactated Ringer's (LR). Water with sodium, potassium, calcium, chloride, and lactate in concentrations more closely approximating blood plasma. Lactate is metabolized by the liver and converted to bicarbonate, which can buffer acidosis. Generally preferred over normal saline for trauma resuscitation when crystalloid administration is indicated.
Other crystalloids exist (Plasma-Lyte, D5W, half-normal saline, hypertonic saline) with specific clinical uses but limited field relevance in tactical medicine.
What crystalloid does and does not do. Crystalloid expands intravascular volume temporarily, raising blood pressure and improving perfusion in the short term. It does not:
Carry oxygen. Crystalloid contains no red blood cells.
Carry clotting factors. Crystalloid contains no plasma proteins, fibrinogen, or other coagulation components.
Stay in the vascular space. Crystalloid distributes throughout the body's water compartments, with most of an administered dose leaving the bloodstream within hours.
The doctrine shift. Through the late 20th century, prehospital trauma protocols called for aggressive crystalloid administration in actively bleeding patients, often 1 to 2 liters or more. Outcome research and combat trauma data over the past two decades documented several harms from this approach:
Dilutional coagulopathy. Large crystalloid volumes dilute the patient's clotting factors, impairing coagulation.
Clot disruption. Restoring blood pressure to normal can dislodge clots that had begun to form, restarting bleeding.
Acidosis. Normal saline in particular contributes to metabolic acidosis when given in large volumes.
Hypothermia. Room-temperature crystalloid lowers core body temperature, contributing to the Lethal Triad.
Edema and reperfusion injury. Excess fluid produces tissue swelling and contributes to organ dysfunction.
Modern doctrine. Current TCCC, TECC, and major civilian trauma protocols favor:
Limited or no crystalloid in actively bleeding trauma patients.
Permissive hypotension targets rather than restoration to normal blood pressure.
Blood products over crystalloid where available.
TXA administration within the three-hour window.
See the Permissive Hypotension and Damage Control Resuscitation entries for the full doctrinal context.
When crystalloid is still appropriate. Crystalloid remains useful for:
Maintaining IV line patency.
Diluting medications for IV administration.
Replacing fluid losses in non-hemorrhagic conditions (heat illness, burns where appropriate per protocol, prolonged transport).
Patients with traumatic brain injury where higher cerebral perfusion pressure is needed (modified permissive hypotension).
Specific clinical situations per protocol.
Procurement implications. The shift in resuscitation doctrine has reduced the volume of crystalloid carried in tactical aid bags while increasing the emphasis on blood products and TXA. Modern aid bag specifications typically include:
A small volume of crystalloid (often 250 to 500 mL bags rather than 1-liter bags) for IV access maintenance and medication delivery.
TXA for trauma patients within the three-hour window.
Blood products where forward-deployed capability exists.
Warming equipment for patients and (where blood products are carried) for the products themselves.
For agencies updating tactical medical specifications, the question is no longer how much crystalloid to carry but rather how to integrate blood product capability and reduce crystalloid reliance.